NTRK2 and cancer: On the other hand, aberrant activation of the BDNF-TrkB axis has been described in age-related pathologies such as lung fibrosis, sarcopenia, cancer, and kidney disease44–48; interestingly, all these processes causing age-associated declines and diseases have been linked to cellular senescence49–54.